Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.
Shadman M, Ahn KW, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, Ahmed N, Hill B, Hossain NM, Riedell P, Gopal AK, Grover N, Frigault M, Brammer J, Ghosh N, Merryman R, Lazaryan A, Ram R, Hertzberg M, Savani B, Awan F, Khimani F, Ahmed S, Kenkre VP, Ulrickson M, Shah N, Kharfan-Dabaja MA, Herrera A, Sauter C, Hamadani M.
Blood Cancer J. 2024 Jul 8;14(1):108. doi: 10.1038/s41408-024-01084-w.
Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study.
Ishikawa T, Yamazaki S, Sato R, Jimbo R, Kobayashi Y, Sato T, Iwanaga A, Sano T, Yokoyama J, Honma T.
Anticancer Res. 2024 Jan;44(1):361-368. doi: 10.21873/anticanres.16819.
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Sockel K, Götze K, Ganster C, Bill M, Georgi JA, Balaian E, Aringer M, Trautmann-Grill K, Uhlig M, Bornhäuser M, Haase D, Thiede C.
Ann Hematol. 2024 Mar;103(3):993-997. doi: 10.1007/s00277-023-05611-w. Epub 2024 Jan 12.
Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review.
He L, Li H, Wang Y, Li W, Gao L, Xu B, Hu J, He P, Pu W, Sun G, Wang Z, Han Q, Liu B, Chen H.
Front Immunol. 2024 Mar 28;15:1354613. doi: 10.3389/fimmu.2024.1354613. eCollection 2024.
Lupus Nephritis Biomarkers: A Critical Review.
Alduraibi FK, Tsokos GC.
Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805.
A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer.
Dediu M, Zielinski C.
Breast Care (Basel). 2020 Feb;15(1):67-71. doi: 10.1159/000500620. Epub 2019 May 27.
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Lu S, Zhang W, Wu L, Wang W, Zhang P; Neotorch Investigators; Fang W, Xing W, Chen Q, Yang L, Mei J, Tan L, Sun X, Xu S, Hu X, Yu G, Yu D, Yang N, Chen Y, Shan J, Xing L, Tian H, Zhang X, Zhou M, Fang H, Wu G, Liu Y, Ye M, Cao L, Jiang J, Li X, Zhu L, Li S, Kang M, Zhong A, Chen K, Wu N, Sun Q, Ma H, Cai K, Wang C, Lin G, Zhu K, Zhang Y, Zhang X, Hu H, Zhang W, Chen J, Yang Z, Hang X, Hu J, Huang Y, Zhang Z, Zhang L, Zhang L, Liu L, Lin D, Zhang J, Chen G, Li Y, Zhu L, Wang W, Yu W, Cao D, Keegan P, Yao S.
JAMA. 2024 Jan 16;331(3):201-211. doi: 10.1001/jama.2023.24735.
Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report.
Zhong G, Zhang X, Guo Z, Gao Y, Zhao B, Liu X, Chen L, Qiao J, Yu C, Wang L, Li Y, Yu L.
Front Immunol. 2024 Feb 29;15:1325860. doi: 10.3389/fimmu.2024.1325860. eCollection 2024.
Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ.
Clin Breast Cancer. 2017 Jul;17(4):245-255. doi: 10.1016/j.clbc.2016.12.010. Epub 2017 Jan 11.
Animal models of lupus nephritis: the past, present and a future outlook.
Katikaneni D, Morel L, Scindia Y.
Autoimmunity. 2024 Dec;57(1):2319203. doi: 10.1080/08916934.2024.2319203. Epub 2024 Mar 13.
